Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CRISP-4-CROPS

Financiado

Cerrado

CRISPR Cas9 technology implementation for improved resistance to Abiotic Stress...

CRISPR Cas9 technology implementation for improved resistance to Abiotic Stress in cereals The overall proposal objective is to overcome the barriers to the recruitment of highly qualified PHD or equivalent specialists in gene editing techniques for agriculture applications, in particular CRISPR-Cas 9 Iden Biotechnology... ver más

14/09/2018

IDEN BIOTECHNOLOGY...

73K€

Presupuesto del proyecto: 73K€

Líder del proyecto

IDEN BIOTECHNOLOGY S.L No se ha especificado una descripción o un objeto social para esta compañía.

TRL 3-4 | 734K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-09-14

INNOSUP-02-2016: European SME innovation Associate -... Specific Challenge:The lack of access to skills, to latest knowledge and capacity to manage innovati...

I+D

Cerrada hace 8 años

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

IDEN BIOTECHNOLOGY S.L

72.50K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 18 meses Fecha Inicio: 2017-03-01
Fecha Fin: 2018-09-14

Líder del proyecto

IDEN BIOTECHNOLOGY S.L No se ha especificado una descripción o un objeto social para esta compañía.

TRL 3-4 | 734K€

Presupuesto del proyecto 73K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The overall proposal objective is to overcome the barriers to the recruitment of highly qualified PHD or equivalent specialists in gene editing techniques for agriculture applications, in particular CRISPR-Cas 9 Iden Biotechnology S.L. is a private agribiotech company founded in 2005 with the mission to serve the needs of the agri-food industry. We aim at exploiting CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats), a newly developed technology for targeted genome modification, to produce new cereal varieties with resistance to abiotic stress (resistance to low temperatures, draught and/or salinity). CRISPR/Cas9, gives scientists the ability to more precisely modify DNA by turning genes on or off or editing DNA. They can pinpoint and remove weakness or insert desired traits already found elsewhere in the species. There are three main advantages of managing to use this technique for crop improvement: Technical, legislative and competitive: • The results obtained are similar to what could be obtained through natural mutations and conventional breeding, though it is directed, more precise and quick. • Besides the technical advantages mentioned above, crops modified with this technique may not fall under the GMOs legislation, opening up new market opportunities, including the European market • Competitive advantage. The crop biotech sector in Europe could have a new innovation tool to overcome the situation defined by the European Academies Science Advisory Council as: The E.U. falling behind international competitors in agricultural innovation and this has implications for E.U. goals for science and innovation. With the help of the associate recruitment we aim at applying this technology to carry out targeted genome modification in cereals, in particular maize or wheat which will help us the development of new improved crop varieties, opening up new market opportunities.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores